Femasys Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FEMY, updated each market day.
FEMY AI Sentiment
AI predicts Femasys Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Femasys Inc. Common Stock
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Sector
Exchange
Market Cap
$23,866,399
Cap Tier
Employees
54
Headquarters
SUWANEE, GA
Listed Since
June 18, 2021
Website
FEMY Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FEMY Volatility
Femasys Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
